Brain–computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental ...

Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) firm ...

US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, ...

BIOPLUS-INTERPHEX KOREA 2026 opened at COEX in Seoul on Wednesday with a first day that made its priorities plain. Hosted by ...

MedTech Innovator (MTI), the world’s largest accelerator of medical device, digital health, and diagnostic companies, has ...

US agency picks Australia's University of Queensland for one of world’s most ambitious biomanufacturing programmes ...

Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, recently celebrated the grand opening of ...

United Imaging Healthcare's uMR Jupiter 5T MRI system has been officially introduced at Hanoi Medical University Hospital ...

· Q1-Q3 2026 total revenue reached RMB 45.54 billion, up 38.6% year-on-year (YoY); revenue from Continuing Operations[2] up ...

Under the terms of the agreement, AI Proteins is eligible to receive over $400 million in upfront and milestone payments, ...

HighTide reports preclinical findings showing HTD1801 reduced cyst expansion in human nephron organoids modelling autosomal ...

GAAP diluted EPS in the third quarter of 2026 was $4.64, 9% growth versus the third quarter of 2025. GAAP operating income ...